Novel oral anticoagulants: the potential relegation of vitamin K antagonists in clinical practice

被引:5
作者
Wrigley, Benjamin J. [1 ]
Lip, Gregory Y. H. [1 ]
Shantsila, Eduard [1 ]
机构
[1] Univ Birmingham, City Hosp, Haemostasis Thrombosis & Vasc Biol Unit, Ctr Cardiovasc Sci, Birmingham B18 7QH, W Midlands, England
关键词
DIRECT THROMBIN INHIBITOR; MOLECULAR-WEIGHT HEPARIN; ACUTE CORONARY SYNDROME; FACTOR-XA INHIBITOR; ATRIAL-FIBRILLATION; VENOUS THROMBOEMBOLISM; DABIGATRAN ETEXILATE; RANDOMIZED-TRIAL; TOTAL HIP; KNEE REPLACEMENT;
D O I
10.1111/j.1742-1241.2010.02351.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:835 / 838
页数:4
相关论文
共 26 条
[1]  
Albers GW, 2003, LANCET, V362, P1691
[2]   Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in Combination With Antiplatelet Therapy After Acute Coronary Syndrome Results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) Trial [J].
Alexander, John H. ;
Becker, Richard C. ;
Bhatt, Deepak L. ;
Cools, Frank ;
Crea, Filippo ;
Dellborg, Mikael ;
Fox, Keith A. A. ;
Goodman, Shaun G. ;
Harrington, Robert A. ;
Huber, Kurt ;
Husted, Steen ;
Lewis, Basil S. ;
Lopez-Sendon, Jose ;
Mohan, Puneet ;
Montalescot, Gilles ;
Ruda, Mikhail ;
Ruzyllo, Witold ;
Verheugt, Freek ;
Wallentin, Lars ;
Darius, Harald ;
Simoons, Maarten ;
Boersma, Eric ;
DeLemos, James ;
Spencer, Fred .
CIRCULATION, 2009, 119 (22) :2877-U39
[3]  
[Anonymous], EFFICACY SAFETY STUD
[4]  
[Anonymous], Dose Finding Study to Determine if BEZ235 Alone or in Combination With RAD001 Decreases the Incidence of Respiratory Tract Infections in the Elderly - Full Text View - ClinicalTrials.gov
[5]   Dabigatran versus Warfarin in Patients with Atrial Fibrillation. [J].
Connolly, Stuart J. ;
Ezekowitz, Michael D. ;
Yusuf, Salim ;
Eikelboom, John ;
Oldgren, Jonas ;
Parekh, Amit ;
Pogue, Janice ;
Reilly, Paul A. ;
Themeles, Ellison ;
Varrone, Jeanne ;
Wang, Susan ;
Alings, Marco ;
Xavier, Denis ;
Zhu, Jun ;
Diaz, Rafael ;
Lewis, Basil S. ;
Darius, Harald ;
Diener, Hans-Christoph ;
Joyner, Campbell D. ;
Wallentin, Lars .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (12) :1139-1151
[6]   Dabigatran etexilate for prevention of venous thromboembolism [J].
Eikelboom, John E. ;
Weitz, Jeffrey I. .
THROMBOSIS AND HAEMOSTASIS, 2009, 101 (01) :2-4
[7]   Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement:: the RE-MODEL randomized trial [J].
Eriksson, B. I. ;
Dahl, O. E. ;
Rosencher, N. ;
Kurth, A. A. ;
Van Dijk, N. ;
Frostick, S. P. ;
Kalebo, P. ;
Christiansen, A. V. ;
Hantel, S. ;
Hettiarachchi, R. ;
Schnee, J. ;
Buller, H. R. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (11) :2178-2185
[8]   A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement:: the BISTRO II randomized trial [J].
Eriksson, BI ;
Dahl, OE ;
Büller, HR ;
Hettiarachchi, R ;
Rosencher, N ;
Bravo, ML ;
Ahnfelt, L ;
Piovella, F ;
Stangier, J ;
Kälebo, P ;
Reilly, P .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (01) :103-111
[9]   Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis -: A randomized trial [J].
Fiessinger, JN ;
Huisman, MV ;
Davidson, BL ;
Bounameaux, H ;
Francis, CW ;
Eriksson, H ;
Lundström, T ;
Berkowitz, SD ;
Nyström, P ;
Thorsén, M ;
Ginsberg, JS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (06) :681-689
[10]   Stroke and thromboembolism in atrial fibrillation: A systematic review of stroke risk factors, risk stratification schema and cost effectiveness data [J].
Hughes, Michael ;
Lip, Gregory Y. H. .
THROMBOSIS AND HAEMOSTASIS, 2008, 99 (02) :295-304